Document Type
Article
Publication Date
8-2022
Publication Title
Human mutation
Keywords
JGM, Exome, Genomics, Humans, Phenotype, Rare Diseases, Whole Exome Sequencing
JAX Source
Hum Mutat 2022 Aug; 43(8):1071-1081
Volume
43
Issue
8
First Page
1071
Last Page
1081
ISSN
1098-1004
PMID
35391505
DOI
https://doi.org/10.1002/humu.24380
Abstract
Rare disease diagnostics and disease gene discovery have been revolutionized by whole-exome and genome sequencing but identifying the causative variant(s) from the millions in each individual remains challenging. The use of deep phenotyping of patients and reference genotype-phenotype knowledge, alongside variant data such as allele frequency, segregation, and predicted pathogenicity, has proved an effective strategy to tackle this issue. Here we review the numerous tools that have been developed to automate this approach and demonstrate the power of such an approach on several thousand diagnosed cases from the 100,000 Genomes Project. Finally, we discuss the challenges that need to be overcome if we are going to improve detection rates and help the majority of patients that still remain without a molecular diagnosis after state-of-the-art genomic interpretation.
Recommended Citation
Jacobsen J,
Kelly C,
Cipriani V,
Research Consortium G,
Mungall C,
Reese J,
Danis D,
Robinson P,
Smedley D.
Phenotype-driven approaches to enhance variant prioritization and diagnosis of rare disease. Hum Mutat 2022 Aug; 43(8):1071-1081
Comments
This study was made possible through access to the data and findings generated by the 100,000 Genomes Project. The 100,000 Genomes Project is managed by Genomics England Limited (a wholly owned company of the Department of Health and Social Care). The 100,000 Genomes Project uses data provided by patients and collected by the National Health Service as part of their care and support.
This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial License.